Preclinical evaluation of nephroprotective potential of a probiotic formulation LOBUN on Cyclosporine-A induced renal dysfunction in Wistar rats
AUTOR(ES)
Venkateswarlu, Kambham, Heerasingh, Thakur, Babu, Chilamakuru Naresh, Triveni, Singirisetty, Manasa, Suroju, Babu, Thumati Nagendra Bhaskar
FONTE
Braz. J. Pharm. Sci.
DATA DE PUBLICAÇÃO
22/06/2017
RESUMO
ABSTRACT The aim of present study was to evaluate the nephroprotective effect of probiotic formulation LOBUN on Cyclosporine A (CsA) induced renal dysfunction in Wistar rats. CsA (20 mg/kg body weight s.c) was administered for 15 days to cause renal dysfunction in Wistar rats. The probiotic formulation LOBUN was administered with the dose of 500 mg/kg body weight (p.o) for twice (TGI) and thrice a day (TGII). The samples were analyzed for the parameters like blood urine nitrogen (BUN), serum creatinine, serum uric acid, total serum protein and urine proteins, urine potassium, urine sodium. The renal functional and histopathological studies revealed that the oral administration of probiotic formulation LOBUN has provided appreciable renoprotection and possibly alleviated the symptoms of Chronic Kidney Disease (CKD) at the dose of 500 mg/kg body weight administered thrice a day and also the results were supported by histopathological findings.
Documentos Relacionados
- Endothelin-1 receptor antagonists protect the kidney against the nephrotoxicity induced by cyclosporine-A in normotensive and hypertensive rats
- Development and characterization of an intraocular biodegradable polymer system containing cyclosporine-A for the treatment of posterior uveitis
- Development and validation of a high performance liquid chromatographic method for determination of cyclosporine-A from biodegradable intraocular implants
- Characterization and in vitro release of cyclosporine-A from poly(D,L-lactide-co-glycolide implants obtained by solvent/extraction evaporation
- Cyclosporine A attenuates apoptosis and necrosis after ischemia-reperfusion-induced renal injury in transiently hyperglycemic rats